NIVFVSSCTX• 6 Months (Normalized)
NIVF vs SCTX (NewGenIvf Group Limited vs Scribe Therapeutics Inc.)
Showing Closing Date Range from Mar 29 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NIVF Performance $0.59
+%
NewGenIvf Group Limited
Normalized Baseline0.00%
SCTX Performance $21.28
+12.18%
Scribe Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin SCTX LEADS
-12.18 pts
SCTX outperforming by 12.18 percentage points
NIVFSCTX
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NIVF SCTX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | NIVF Price | NIVF Gain (%) | SCTX Price | SCTX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $- | $21.28 | +12.18% | - | |
| Sep 24, 2026 | $- | $21.61 | +13.92% | - | |
| Sep 23, 2026 | $0.59 | -96.64% | $26.53 | +39.85% | -136.49% |
| Sep 22, 2026 | $0.73 | -95.82% | $28.07 | +47.97% | -143.79% |
| Sep 21, 2026 | $0.72 | -95.90% | $28.05 | +47.87% | -143.77% |
| Sep 18, 2026 | $0.72 | -95.90% | $33.00 | +73.96% | -169.86% |
| Sep 17, 2026 | $0.72 | -95.93% | $32.14 | +69.43% | -165.36% |
| Sep 16, 2026 | $0.79 | -95.53% | $29.10 | +53.40% | -148.93% |
| Sep 15, 2026 | $0.84 | -95.21% | $31.66 | +66.90% | -162.11% |
| Sep 14, 2026 | $0.93 | -94.71% | $29.42 | +55.09% | -149.80% |
| Sep 11, 2026 | $1.06 | -93.96% | $29.74 | +56.77% | -150.73% |
| Sep 10, 2026 | $1.11 | -93.68% | $29.47 | +55.35% | -149.03% |
| Sep 09, 2026 | $1.10 | -93.73% | $29.41 | +55.03% | -148.76% |
| Sep 08, 2026 | $1.11 | -93.68% | $31.34 | +65.21% | -158.89% |
| Sep 04, 2026 | $1.14 | -93.50% | $28.67 | +51.13% | -144.63% |
Page 1 of 9